191P Preliminary biomarker and safety results of SQZ-PBMC-HPV at RP2D in monotherapy and combination with checkpoint inhibitors in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors

Subjects

Subjects :

Oncology
Immunology and Allergy

Details

ISSN :

25900188

Volume :

16

Database :

OpenAIRE

Journal :

Immuno-Oncology and Technology

Accession number :

edsair.doi...........95cfc4bcd723b829d5d56988f5263dba

Full Text :

https://doi.org/10.1016/j.iotech.2022.100303